Clearside Biomedical (CLSD) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CLSD Hot Sheet
Join SI Premium – FREE
Clearside Biomedical (NASDAQ: CLSD) reported Q3 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $1.04 million versus the consensus estimate of $130 thousand.
For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
